Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare is one of the leading ayurvedic healthcare system providers in India. The company is providing healthcare services for the last ten years.
- Market Cap ₹ 7,033 Cr.
- Current Price ₹ 566
- High / Low ₹ 850 / 492
- Stock P/E 31.7
- Book Value ₹ 37.6
- Dividend Yield 0.19 %
- ROCE 64.1 %
- ROE 61.3 %
- Face Value ₹ 2.00
Pros
- Debtor days have improved from 49.0 to 31.8 days.
Cons
- Stock is trading at 15.2 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Consumer Discretionary Consumer Services Leisure Services Wellness
Part of Nifty Microcap 250 Nifty Total Market Nifty Smallcap 500
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| 147 | 205 | 469 | 801 | |
| 128 | 159 | 328 | 452 | |
| Operating Profit | 18 | 46 | 141 | 349 |
| OPM % | 12% | 22% | 30% | 44% |
| 1 | 3 | 7 | 8 | |
| Interest | 1 | 1 | 11 | 13 |
| Depreciation | 3 | 3 | 29 | 48 |
| Profit before tax | 15 | 44 | 108 | 297 |
| Tax % | 26% | 24% | 26% | 25% |
| 11 | 34 | 80 | 222 | |
| EPS in Rs | 1.23 | 2.72 | 6.43 | 17.85 |
| Dividend Payout % | 0% | 8% | 0% | 25% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 58% |
| TTM: | 71% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 88% |
| TTM: | 178% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 104% |
| 1 Year: | 5% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 61% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 10 | 14 | 25 | 25 |
| Reserves | 26 | 112 | 231 | 442 |
| 7 | 1 | 117 | 127 | |
| 18 | 24 | 46 | 80 | |
| Total Liabilities | 62 | 151 | 419 | 674 |
| 29 | 60 | 255 | 294 | |
| CWIP | 5 | 1 | 11 | 2 |
| Investments | 0 | 5 | 4 | 110 |
| 28 | 86 | 149 | 269 | |
| Total Assets | 62 | 151 | 419 | 674 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| 16 | 15 | 84 | 254 | |
| -18 | -33 | -64 | -202 | |
| -5 | 48 | -22 | -59 | |
| Net Cash Flow | -7 | 29 | -2 | -7 |
| Free Cash Flow | -2 | -15 | 45 | 221 |
| CFO/OP | 112% | 50% | 84% | 94% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor Days | 23 | 39 | 66 | 32 |
| Inventory Days | 149 | 85 | 78 | 81 |
| Days Payable | 109 | 126 | 106 | 92 |
| Cash Conversion Cycle | 62 | -1 | 38 | 20 |
| Working Capital Days | -12 | 28 | 30 | 58 |
| ROCE % | 52% | 64% |
Insights
In beta| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Active Operational Centres centres |
|
|||||
| IPD Patient Volumes patients |
||||||
| Medicine Order Volumes lakh orders |
||||||
| OPD Patient Volumes lakh patients |
||||||
| Operational Beds beds |
||||||
| Beds Occupied beds |
||||||
| SKUs in Portfolio SKUs |
||||||
Extracted by Screener AI
Documents
Announcements
-
Receipt Of GST Appreciation Certificates From The Central Board Of Indirect Taxes And Customs (CBIC)
2d - Received CBIC GST appreciation certificates for Maharashtra, Uttar Pradesh and Haryana on 11 July 2026.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
3 Jul - Filed Regulation 74(5) certificate for quarter ended June 30, 2026.
-
Closure of Trading Window
26 Jun - Trading window closed from July 1, 2026 until 48 hours after Q1 FY2027 results.
-
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015, As Amended ('SEBI Listing Regulations') - Sale Of Land And Building
19 Jun - Board approved sale of Mohali land and building for ₹9.05 crore, with lease-back continuation of operations.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
17 Jun - Intimation of Analyst / Investor meet under Regulation 30 of the SEBI (LODR) Regulations, 2015 scheduled to be held on 23rd June, 2026.
Annual reports
Concalls
-
Jun 2026Transcript PPT REC
-
May 2026TranscriptAI SummaryPPT
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT
-
Aug 2025TranscriptAI SummaryPPT
-
Jul 2025TranscriptPPTREC
-
May 2025Transcript PPT REC
-
Nov 2024Transcript PPT
-
Nov 2024TranscriptPPT REC
-
May 2024Transcript PPT
-
Feb 2024TranscriptAI SummaryPPT
-
Aug 2023TranscriptAI SummaryPPT
-
Aug 2023TranscriptAI SummaryPPT
Business Segment:[1][2]
a) Hospitals & Clinics Portfolio
Jeena Sikho Lifecare Limited (JSLL) operates a network of 119 active centers (61 hospitals + 58 clinics/day-care centres), across 23 states and 100+ cities/towns. The hospitals have 2300 operational beds, with another 445 beds in the pipeline. 561 beds were added in FY26. ompany has ~592 certified Ayurveda doctors and ~780 supporting healthcare personnel.